Join Us at Cell Bio 2022
Join us December 3-7 at Cell Bio 2022 and check out our poster sessions at the event to learn about our new models and whole transcriptome datasets.
New Monkeypox DNA and Heat-inactivated Virus
Now available—quantitative, fully sequenced genomic DNA and heat-inactivated virus derived from the clinical Monkeypox virus strain hMPX/USA/MA001/2022.
Check Out our Application Data
Did you miss our posters at SITC 2022? Watch a recording or download a PDF of our posters to learn about the development and application of CAR-T target luciferase reporter cells and PD-L1 reporter cells.
Recapping the Society for Immunotherapy of Cancer's (SITC) 2022 Event
The five-day meeting of the best minds in tumor immunology was a masterclass in harnessing the power of the immune system.
New Respiratory Inclusivity and Exclusivity Panels
ATCC’s new panels comprise nucleic acids or heat-inactivated material derived from pathogens commonly cited for use as control materials in SARS-CoV-2 EUA submissions and/or FDA 510(k) submissions.
See Our Latest Cancer Models
Have you checked out the HCMI collection recently? We are continually adding 3-D patient-derived cancer models to our portfolio. Check out our newest releases.
Best Practices for Sample Storage
Read the recent Biocompare article to see what Debra Lopez, Supply Chain Senior Director at ATCC, has to say about how to store and manage biological samples to ensure they stay protected and traceable.
Resources for Therapeutic Development
Immuno-oncology therapeutic development
Cancer immunotherapy has emerged as an exciting new approach for cancer treatment, and immuno-oncology is one of the fastest growing fields in oncology. The development of immunomodulatory drugs and biologics dictate a clear need for human cell-based models to evaluate immune activation. To answer this need, ATCC provides a large collection of fully characterized and authenticated cell lines, human primary cells, and advanced cell models.Explore immuno-oncology models
Products for toxicity testing
We provide the cells, media, and reagents needed to explore each step of the in vitro preclinical testing process—from modeling, screening, and characterization to exploratory toxicology, pharmacokinetics, and metabolism. Our growing portfolio of toxicology resources includes renal, neural, airway, and skin cell models for use in high-content screening, permeability assays, metabolic stability and survival studies, transport activity measurement, and more.Find toxicology resources
Human Cancer Models Initiative
ATCC is collaborating with the Human Cancer Models Initiative (HCMI) to offer scientists a wide variety of next-generation 2-D and 3-D patient-derived in vitro cancer models, including organoids. ATCC is committed to making available a growing collection of models generated by the HCMI, which will include both common as well as rare and understudied examples of cancer from numerous tissues. These HCMI models are valuable tools to study cancer, identify and target novel therapies, and facilitate translational cancer research.Find next-generation models
Advanced Biological Models for Cancer Research
ATCC Genome Portal
Enhanced Authentication Initiative
ATCC is not only enriching the characterization of our biological collections by using next-generation sequencing, we are also making those data available to everyone through the ATCC Genome Portal.
ATCC Genome Portal
The ATCC Genome Portal makes it easy to find the high-quality whole-genome sequencing data needed for your research. Using your ATCC login, you can easily search, download, and analyze hundreds of high quality genomes.
ATCC (American Type Culture Collection) is a nonprofit, global biological resource center and standards organization and the leading developer and supplier of authenticated cells lines and microorganisms. We leverage our rich history and knowledge to provide the products, services, and resources scientists need to conduct critical life science research.